Latest filing published 24 Aug 2017 for NUTRACEUTICAL INTERNATIONAL CORP.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stanley E. Soper: trading record in brief
This profile gathers the share dealings of Stanley E. Soper in Nutraceutical International Corp. The record holds 120 filings, for trades running from 15 December 2006 to 23 August 2017.
In open-market terms, that means 5 purchases worth €65k on one side and 37 sales worth €1.3M on the other. On balance, insiders were net sellers of €1.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 38 share grants and 28 option exercises.
In size, the median ticket on the buying side is €1,268.
The latest filing, published on 24 August 2017, reports a transaction in Nutraceutical International Corp. The clock since the last published purchase (28 December 2009) now reads 6,159 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stanley E. Soper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,237 sharesCommon StockSEC:0001396677-17-000032:0
- 1,400 sharesCommon StockSEC:0001396677-17-000032:1
- 19,074 sharesCommon StockSEC:0001396677-17-000032:2
- 63.53 shares@ US$31.481.5% of flowCommon StockSEC:0001396677-17-000024:0
- 64.78 shares@ US$30.881.6% of flowCommon StockSEC:0001396677-17-000019:0
- 58.18 shares@ US$34.381.6% of flowCommon StockSEC:0001396677-17-000012:0
- 59.35 shares@ US$33.701.6% of flowCommon StockSEC:0001396677-17-000008:0
- 56.06 shares@ US$35.681.6% of flowCommon StockSEC:0001396677-17-000004:0
- 2,898.55 shares@ US$34.5079.8% of flowCommon StockSEC:0001396677-16-000136:0
- 61.3 shares@ US$32.631.6% of flowCommon StockSEC:0001396677-16-000130:0
- 70.11 shares@ US$28.531.5% of flowCommon StockSEC:0001396677-16-000123:0
- 64.79 shares@ US$30.871.5% of flowCommon StockSEC:0001396677-16-000118:0
- 77.81 shares@ US$25.701.5% of flowCommon StockSEC:0001396677-16-000113:0
- 78.56 shares@ US$25.461.5% of flowCommon StockSEC:0001396677-16-000109:0
- 170.64 shares0Common StockSEC:0001396677-16-000099:0
- 170.64 shares0Common StockSEC:0001396677-16-000099:1
- 86.23 shares@ US$23.201.5% of flowCommon StockSEC:0001396677-16-000099:2
- 83.65 shares@ US$23.911.5% of flowCommon StockSEC:0001396677-16-000094:0
- 86.99 shares@ US$22.991.5% of flowCommon StockSEC:0001396677-16-000090:0
- 3,818 shares@ US$14.22Common StockSEC:0001396677-15-000031:0
- 3,818 shares@ US$20.00Common StockSEC:0001396677-15-000031:1
- 5,000 shares@ US$14.22Common StockSEC:0001396677-15-000026:0
- 5,000 shares@ US$19.34Common StockSEC:0001396677-15-000026:1
- 6,805 shares@ US$14.22Common StockSEC:0001396677-15-000025:0
- 6,805 shares@ US$20.01Common StockSEC:0001396677-15-000025:1
25 of 108 declarations